Increasing trust in real-world evidence through evaluation of observational data quality

被引:50
|
作者
Blacketer, Clair [1 ,2 ]
Defalco, Frank J. [1 ]
Ryan, Patrick B. [1 ,3 ]
Rijnbeek, Peter R. [2 ]
机构
[1] Janssen Res & Dev LLC, Observat Hlth Data Analyt, 1125 Trenton Harbourton Rd, Titusville, NJ 08560 USA
[2] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands
[3] Columbia Univ, Dept Biomed Informat, New York, NY USA
关键词
Data Quality; Data Standardization; Common Data Model; Real World Evidence;
D O I
10.1093/jamia/ocab132
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective: Advances in standardization of observational healthcare data have enabled methodological breakthroughs, rapid global collaboration, and generation of real-world evidence to improve patient outcomes. Standardizations in data structure, such as use of common data models, need to be coupled with standardized approaches for data quality assessment. To ensure confidence in real-world evidence generated from the analysis of real-world data, one must first have confidence in the data itself. Materials and Methods: We describe the implementation of check types across a data quality framework of conformance, completeness, plausibility, with both verification and validation. We illustrate how data quality checks, paired with decision thresholds, can be configured to customize data quality reporting across a range of observational health data sources. We discuss how data quality reporting can become part of the overall realworld evidence generation and dissemination process to promote transparency and build confidence in the resulting output. Results: The Data Quality Dashboard is an open-source R package that reports potential quality issues in an OMOP CDM instance through the systematic execution and summarization of over 3300 configurable data quality checks. Discussion: Transparently communicating how well common data model-standardized databases adhere to a set of quality measures adds a crucial piece that is currently missing from observational research. Conclusion: Assessing and improving the quality of our data will inherently improve the quality of the evidence we generate.
引用
收藏
页码:2251 / 2257
页数:7
相关论文
共 50 条
  • [41] Real-World Data as an Evidence Source in Nuclear Medicine
    Bourla, Ariel B.
    Herrmann, Ken
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (02) : 156 - 157
  • [42] Real-world Data for Clinical Evidence Generation in Oncology
    Khozin, Sean
    Blumenthal, Gideon M.
    Pazdur, Richard
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (11):
  • [43] The use of real-world data/evidence in regulatory submissions
    Song, Fuyu
    Zang, Chenxuan
    Ma, Xinyi
    Hu, Sifan
    Sun, Qiqing
    Chow, Shein-Chung
    Sun, Hongqiang
    CONTEMPORARY CLINICAL TRIALS, 2021, 109
  • [44] ASSESSMENT OF REAL-WORLD DATA SOURCES AND A HYBRID APPROACH IN REAL-WORLD EVIDENCE GENERATION USING UNHARMONIZED DATA SOURCES
    Toh, K. C.
    Goh, C. H.
    Goh, V
    Dong, Z.
    Dumpala, L. S.
    Maity, S.
    Wu, J. Y.
    Kleinman, N.
    Lee, Y.
    VALUE IN HEALTH, 2024, 27 (06) : S407 - S407
  • [45] Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
    Aboseif, Albert
    Roos, Izanne
    Krieger, Stephen
    Kalincik, Tomas
    Hersh, Carrie M.
    NEUROLOGIC CLINICS, 2024, 42 (01) : 203 - 227
  • [46] Real-world evidence (RWE) study to access motor vehicle accidents data: Real-world data landscaping and feasibility
    Li, Hu
    Phinney, Michael
    Khanna, Rashna
    Bragg, Sonja M.
    Clemmer, Tammy
    Oakkar, Eva
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 611 - 611
  • [47] Real-World Evidence: Integrating Machine Learning with Real-World Big Data for Predictive Analytics in Healthcare
    Vecchio, Nicolas
    CARDIOLOGY, 2024,
  • [48] FROM CLINICAL TRIAL TO REAL-WORLD EVIDENCE: A SYSTEMATIC APPROACH TO IDENTIFYING DATA SOURCES FOR OBSERVATIONAL RESEARCH
    Parasuraman, B.
    Tomic, K. S.
    Winchester, C. C.
    Westergaard, M.
    Johansson, S.
    VALUE IN HEALTH, 2013, 16 (07) : A583 - A584
  • [49] Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
    Chen, Jie
    Gruber, Susan
    Lee, Hana
    Chu, Haitao
    Lee, Shiowjen
    Tian, Haijun
    Wang, Yan
    He, Weili
    Jemielita, Thomas
    Song, Yang
    Tamura, Roy
    Tian, Lu
    Zhao, Yihua
    Chen, Yong
    van Der Laan, Mark
    Nie, Lei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (04) : 946 - 960
  • [50] Comparison of two assessments of real-world data and real-world evidence for regulatory decision-making
    Yuan, Lily
    Rahman, Motiur
    Concato, John
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):